Cite
HARVARD Citation
Orkin, C. et al. (2020). Fixed-dose combination bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir-containing regimens for initial treatment of HIV-1 infection: week 144 results from two randomised, double-blind, multicentre, phase 3, non-inferiority trials. Lancet. 7 (6), pp. e389-e400. [Online].